smartseq stranded kit (TaKaRa)

TaKaRa is a verified supplier

TaKaRa manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

TaKaRa smartseq stranded kit
Smartseq Stranded Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 343 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/smart+seq+stranded+kit/SMART-Seq+Stranded+Kit/pm42033129-76-5-8
Average 96 stars, based on 343 article reviews

smartseq stranded kit - by Bioz Stars, 2026-10

96/100 stars

Images

other:

Article Title: Establishment of Salivary Gland Tumors Arising in Salivary Gland-Specific EWSR1::ATF1 Transgenic Mice.
Article Snippet: Libraries were prepared using the SMARTseq Stranded kit (Takara Bio), and sequenced on an Illumina NovaSeq 6000 platform (150 bp paired- end), yielding an average of 61 million read pairs per sample (range: 38–101 million).

Article Title: AMPK-p38 axis converts human pluripotent stem cells to naive state
Article Snippet: SMART-Seq® Stranded Kit , Takara Bio , Cat# 634442.

cDNA Synthesis:

Article Title: Juvenile social isolation induces gene expression alterations and histone modification dysregulations in nucleus accumbens (NAc) neurons
Article Snippet: .. After removing the supernatant, nuclei were resuspended in 3.5 μl of water and transferred to a new tube for cDNA synthesis and library preparation using the SMART-seq Stranded Kit (Takara, #634447) according to the manufacturer’s protocol. .. Library concentrations were assessed using the TapeStation system (Agilent), and sequencing was performed on the DNB-seq platform (MGI) to obtain 50-base single-end reads.

RNA sequencing:

Article Title: Intraductal Papillary Squamous Neoplasm (IPSN) of the Pancreas: Histologic and Molecular Characterization of a Novel and Distinct Intraductal Cancer Precursor.
Article Snippet: .. RNAseq was performed using SMART-Seq Stranded kit (Takara Bio, Shiga, Japan), according to the manufacturer’s instructions. .. The RNA libraries were sequenced on NovaSeq 6000 (Illumina, San Diego, California).

Sequencing:

Article Title: circPDE4B downregulation triggers GEMIN5‑dependent translational stress response and autophagy to reduce MAPT pathology.
Article Snippet: .. The sequencing libraries were prepared using SMART-Seq Total RNA High Input kit following manufacturer’s instructions (Takara Bio USA, Inc., Cat# 635046). .. purified using the Qiagen RNeasy Plus Mini Kit (Qiagen, Cat# 74134) according to the manufacturer’s instructions

Article Title: Tumor-associated calcium signal transducer 2 expression as a promising therapeutic target in esophageal squamous cell carcinoma: a combined the Cancer Genome Atlas and an institutional cohort.
Article Snippet: Briefly, total RNA was extracted from two FFPE tissue slices using an miRNeasy FFPE kit (Qiagen) [20]. .. Whole-transcriptome sequencing was performed using the SMART-Seq Stranded kit (Takara Bio Europe) for library preparation and NextSeq 500, single end 75 bp (Illumina) for sequencing [21]. ..

Article Title: A multi-omics analysis of advanced triple-negative breast cancer identifies predictors to chemo-immunotherapy and on-treatment dynamics.
Article Snippet: .. CeGaT used KAPA RNA Hyper Prep (Roche) or SMART-Seq Stranded (Takara Bio) for the library preparation and sequencing on the NovaSeq6000, at 2 × 100 bp, at a depth of 100 Mio paired end reads. ..

RNA Sequencing:

Article Title: Tofogliflozin alters amino acid metabolism in gut microbiota linked to hepatic transcriptomic signatures in MASLD.
Article Snippet: Background A deeper understanding of the relationship between dysbiotic gut microbiota and liver tissue-level molecular and histopathological phenotypes in metabolic dysfunction-associated steatotic liver disease (MASLD) remains needed.. We aimed to characterize the associations between gut microbial metabolic functions and treatment responses in participants with MASLD.. Methods We performed a prespecified sub-analysis of a randomized controlled trial comparing the sodium–glucose cotransporter 2 inhibitor (SGLT2i) tofogliflozin and the sulfonylurea (SU) glimepiride in participants with MASLD and type 2 diabetes (ClinicalTrials.gov NCT02649465).

Review